BREAKING NEWS: Unnatural Products raise a further $45M in Series B financing for a new class of medicines built on synthetic macrocyclic peptides - meet them in April
Industry News: Novo Nordisk teams with Langer-founded biotech Vivtex for oral obesity drugs - meet them in April
Industry News: Novartis signs macrocyclic deal with Unnatural Products - meet them in April
Industry News: Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly - meet them in April
Industry News: PeptiDream Announces Achievement Milestone with Johnson & Johnson - meet them in April